Kentaro Miyake Selected Research

Kentaro Miyake Research Topics

Disease

78	Neoplasms (Cancer) 04/2022 - 01/2017
18	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 01/2017
17	Neoplasm Metastasis (Metastasis) 02/2022 - 05/2017
15	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022 - 05/2017
15	Osteosarcoma (Osteogenic Sarcoma) 07/2021 - 01/2017
7	Liposarcoma 07/2020 - 01/2018
7	Ewing Sarcoma (Sarcoma, Ewing) 05/2019 - 05/2017
6	Melanoma (Melanoma, Malignant) 11/2020 - 10/2017
4	Adenocarcinoma 02/2021 - 05/2017
4	Colonic Neoplasms (Colon Cancer) 12/2020 - 07/2019
3	Lymphatic Metastasis 07/2022 - 02/2022
3	Necrosis 07/2021 - 09/2019
3	Breast Neoplasms (Breast Cancer) 05/2020 - 02/2019
3	Synovial Sarcoma (Synovioma) 06/2019 - 04/2018
2	Cholangiocarcinoma 07/2022 - 08/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2020 - 04/2019
2	Leiomyosarcoma 01/2019 - 01/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 01/2017
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2018 - 01/2018
1	Inflammation (Inflammations) 07/2022
1	Klatskin Tumor 04/2022
1	Primitive Neuroectodermal Tumors (PNET) 12/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2021
1	Anaphylaxis (Anaphylactic Shock) 10/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 08/2021
1	Margins of Excision 08/2021
1	Lung Neoplasms (Lung Cancer) 02/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2020
1	Hemorrhage 05/2020
1	Brain Neoplasms (Brain Tumor) 05/2020
1	Rhabdomyosarcoma 02/2020
1	Malnutrition (Nutritional Deficiencies) 12/2019

Drug/Important Bio-Agent (IBA)

32	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021 - 06/2017
23	L-methionine gamma-lyaseIBA 01/2022 - 01/2017
16	Methionine (L-Methionine)FDA Link 04/2022 - 01/2017
14	Gemcitabine FDA Link 04/2022 - 11/2017
13	Pharmaceutical PreparationsIBA 10/2021 - 05/2017
11	Temozolomide (Temodar)FDA LinkGeneric 07/2020 - 09/2017
8	pazopanib FDA Link 07/2020 - 01/2017
7	Docetaxel (Taxotere)FDA Link 07/2020 - 11/2017
6	palbociclibIBA 07/2021 - 01/2018
5	Red Fluorescent ProteinIBA 02/2022 - 05/2017
5	Green Fluorescent ProteinsIBA 02/2021 - 05/2017
5	eribulin FDA Link 07/2020 - 01/2018
5	TrabectedinIBA 07/2020 - 09/2017
5	olaratumabIBA 09/2019 - 01/2019
4	Irinotecan (Camptosar)FDA LinkGeneric 05/2019 - 11/2017
4	130-nm albumin-bound paclitaxelIBA 03/2019 - 01/2017
3	Histones (Histone)IBA 04/2022 - 12/2020
3	regorafenibIBA 11/2020 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 12/2017
3	Caffeine (No Doz)FDA LinkGeneric 02/2020 - 10/2018
2	Lysine (L-Lysine)FDA Link 04/2022 - 01/2022
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2021 - 05/2020
2	Everolimus FDA Link 07/2021 - 09/2019
2	Cyclin-Dependent Kinase 4IBA 07/2021 - 11/2017
2	AntigensIBA 02/2021 - 11/2020
2	Fluorouracil (Carac)FDA LinkGeneric 11/2020 - 09/2019
2	Drug CombinationsIBA 11/2020 - 09/2019
2	osimertinibIBA 05/2020 - 04/2019
2	ErbB Receptors (EGF Receptor)IBA 05/2020 - 04/2019
2	Tyrosine Kinase InhibitorsIBA 05/2020 - 04/2019
2	Sunitinib (Sutent)FDA Link 09/2019 - 01/2018
2	Sorafenib (BAY 43-9006)FDA Link 09/2019 - 08/2019
2	Fluorescent Dyes (Fluorescent Probes)IBA 12/2018 - 04/2018
2	Imatinib Mesylate (Gleevec)FDA Link 06/2018 - 01/2018
2	LyasesIBA 01/2018 - 01/2017
1	Hemoglobins (Hemoglobin)IBA 07/2022
1	BismuthIBA 04/2022
1	Carboplatin (JM8)FDA LinkGeneric 10/2021
1	BilirubinIBA 08/2021
1	TOR Serine-Threonine KinasesIBA 07/2021
1	MTOR InhibitorsIBA 07/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	histone H3 trimethyl Lys4IBA 12/2020
1	PlasticsIBA 12/2020
1	LigandsIBA 11/2020
1	tigatuzumabIBA 11/2020
1	Bevacizumab (Avastin)FDA Link 05/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2020
1	Vinorelbine (Navelbine)FDA LinkGeneric 05/2020
1	olaparibIBA 05/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 02/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2020
1	Decitabine FDA Link 01/2020
1	Pioglitazone (Actos)FDA Link 10/2019
1	Messenger RNA (mRNA)IBA 10/2019

Therapy/Procedure

48	Therapeutics 02/2022 - 01/2017
18	Drug Therapy (Chemotherapy) 07/2022 - 11/2017
6	Aftercare (After-Treatment) 05/2020 - 01/2017
5	Neoadjuvant Therapy 04/2022 - 09/2017
3	Oral Administration 06/2018 - 01/2018
2	Absorbable Gelatin Sponge 01/2021 - 12/2020
2	Pancreaticoduodenectomy 05/2020 - 12/2019
2	Laparotomy 06/2018 - 01/2018
2	Immunotherapy 09/2017 - 06/2017
1	Radiotherapy 07/2022
1	Pancreatectomy 12/2021
1	Pancreaticojejunostomy 05/2020
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 05/2020